Metabolic implications when employing heavy pre- and post-exercise rapid-acting insulin reductions to prevent hypoglycaemia in type 1 diabetes patients: a randomised clinical trial

Matthew D Campbell, Mark Walker, Michael I Trenell, Steven Luzio, Gareth Dunseath, Daniel Tuner, Richard M Bracken, Stephen C Bain, Mark Russell, Emma J Stevenson, Daniel J West, Matthew D Campbell, Mark Walker, Michael I Trenell, Steven Luzio, Gareth Dunseath, Daniel Tuner, Richard M Bracken, Stephen C Bain, Mark Russell, Emma J Stevenson, Daniel J West

Abstract

Aim: To examine the metabolic, gluco-regulatory-hormonal and inflammatory cytokine responses to large reductions in rapid-acting insulin dose administered prandially before and after intensive running exercise in male type 1 diabetes patients.

Methods: This was a single centre, randomised, controlled open label study. Following preliminary testing, 8 male patients (24±2 years, HbA1c 7.7±0.4%/61±4 mmol.l-1) treated with insulin's glargine and aspart, or lispro attended the laboratory on two mornings at ∼08:00 h and consumed a standardised breakfast carbohydrate bolus (1 g carbohydrate.kg-1BM; 380±10 kcal) and self-administered a 75% reduced rapid-acting insulin dose 60 minutes before 45 minutes of intensive treadmill running at 73.1±0.9% VO2peak. At 60 minutes post-exercise, patients ingested a meal (1 g carbohydrate.kg-1BM; 660±21 kcal) and administered either a Full or 50% reduced rapid-acting insulin dose. Blood glucose and lactate, serum insulin, cortisol, non-esterified-fatty-acids, β-Hydroxybutyrate, and plasma glucagon, adrenaline, noradrenaline, IL-6, and TNF-α concentrations were measured for 180 minutes post-meal.

Results: All participants were analysed. All glycaemic, metabolic, hormonal, and cytokine responses were similar between conditions up to 60 minutes following exercise. Following the post-exercise meal, serum insulin concentrations were lower under 50% (p<0.05) resulting in 75% of patients experiencing hyperglycaemia (blood glucose ≥8.0 mmol.l-1; 50% n = 6, Full n = 3). β-Hydroxybutyrate concentrations decreased similarly, such that at 180 minutes post-meal concentrations were lower than rest under Full and 50%. IL-6 and TNF-α concentrations remained similar to fasting levels under 50% but declined under Full. Under 50% IL-6 concentrations were inversely related with serum insulin concentrations (r = -0.484, p = 0.017).

Conclusions: Heavily reducing rapid-acting insulin dose with a carbohydrate bolus before, and a meal after intensive running exercise may cause hyperglycaemia, but does not augment ketonaemia, raise inflammatory cytokines TNF-α and IL-6 above fasting levels, or cause other adverse metabolic or hormonal disturbances.

Trial registration: ClinicalTrials.gov NCT01531855.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. A–B. Time-course changes in serum…
Figure 1. A–B. Time-course changes in serum insulin (A) and blood glucose (B) from rest.
Full  =  black squares, 50%  =  black diamond.* indicates significantly different from Full (p<0.05). Transparent sample point within a condition indicates a significant difference from pre-exercise meal concentrations (p<0.05). Vertical dashed line break indicates post-exercise intervention. NOTE: test meal and insulin were administered immediately following rest and meal sample points.
Figure 2. A–B. Time-course changes in IL-6…
Figure 2. A–B. Time-course changes in IL-6 (A) and TNF-α (B) from rest.
Full  =  black squares, 50%  =  black diamond.* indicates significantly different from Full (p<0.05). Transparent sample point within a condition indicates a significant difference from pre-exercise meal concentrations (p<0.05). Vertical dashed line break indicates post-exercise intervention. NOTE: test meal and insulin were administered immediately following rest and meal sample points.

References

    1. Chu L, Hamilton J, Riddell MC (2011) Clinical management of the physically active patient with type 1 diabetes. Physiol Sports Med 39: 64–77.
    1. West DJ, Morton RD, Bain SC, Stephens JW, Bracken RM (2010) Blood glucose responses to reductions in pre-exercise rapid-acting insulin for 24 h after running in individuals with type 1 diabetes. J Sports Sci 28: 781–788.
    1. Rabasa-Lhoret R, Bourque J, Ducros F, Chiasson JL (2001) Guidelines for premeal insulin dose reduction for postprandial exercise of different intensities and durations in type 1 diabetic subjects treated intensively with a basal-bolus insulin regimen (ultralente-lispro). Diabetes Care 24: 625–630.
    1. Campbell MD, Walker M, Trenell MI, Jakovljevic DG, Stevenson EJ, et al. (2013) Large Pre-and Postexercise Rapid-Acting Insulin Reductions Preserves Glycemia and Prevents Early-but Not Late-Onset Hypoglycemia in Patients With Type 1 Diabetes. Diabetes Care 36: 2217–2224.
    1. Khani S, Tayek JA (2001) Cortisol increases gluconeogenesis in humans: its role in the metabolic syndrome. Clin Sci 101: 739–747.
    1. Laffel L (2000) Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Rev 15: 412–426.
    1. Rosa JS, Flores RL, Oliver SR, Pontello AM, Zaldivar FP, et al. (2008) Sustained IL-1α, IL-4, and IL-6 elevations following correction of hyperglycemia in children with type 1 diabetes mellitus. Pediatric Diabetes 9: 9–16.
    1. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, et al. (2002) Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans role of oxidative stress. Circulation 106: 2067–2072.
    1. Targher G, Zenari L, Bertolini L, Muggeo M, Zoppini G (2001) Elevated levels of interleukin-6 in young adults with type 1 diabetes without clinical evidence of microvascular and macrovascular complications. Diabetes Care 24: 956–957.
    1. De Rekeneire N, Peila R, Ding J, Colbert LH, Visser M, et al. (2006) Diabetes, Hyperglycemia, and Inflammation in Older Individuals The Health, Aging and Body Composition study. Diabetes Care 29: 1902–1908.
    1. Febbraio MA, Pedersen BK (2005) Contraction-induced myokine production and release: is skeletal muscle an endocrine organ? Exerc Sport Sci Rev 33: 114–119.
    1. Stouthard J, Romijn JA, Van der Poll T, Endert E, Klein S, et al. (1995) Endocrinologic and metabolic effects of interleukin-6 in humans. Am J Physiol-Endoc Metab 268: E813–E819.
    1. Karavanaki K, Kakleas K, Georga S, Bartzeliotou Α, Mavropoulos G, et al. (2012) Plasma high sensitivity C-reactive protein and its relationship with cytokine levels in children with newly diagnosed type 1 diabetes and ketoacidosis. Clin Biochem 45: 1383–1388.
    1. Karavanaki K, Karanika E, Georga S, Bartzeliotou A, Tsouvalas M, et al. (2011) Cytokine response to diabetic ketoacidosis (DKA) in children with type 1 diabetes (T1DM). Endocr J58: 1045.
    1. Petersen AMW, Pedersen BK (2005) The anti-inflammatory effect of exercise. J App Phys 98: 1154–1162.
    1. Ostrowski K, Rohde T, Asp S, Schjerling P, Pedersen BK (1999) Pro-and anti-inflammatory cytokine balance in strenuous exercise in humans. J Physiol 515: 287–291.
    1. Sprenger H, Jacobs C, Nain M, Gressner A, Prinz H, et al. (1992) Enhanced release of cytokines, interleukin-2 receptors, and neopterin after long-distance running. Clin immunol and immunop 63: 188–195.
    1. Drenth J, Van Uum S, Van Deuren M, Pesman GJ, Van der Ven-Jongekrijg J, et al. (1995) Endurance run increases circulating IL-6 and IL-1ra but downregulates ex vivo TNF-alpha and IL-1 beta production. J App Physiol 79: 1497–1503.
    1. Nehlsen-Cannarella S, Fagoaga O, Nieman D, Henson D, Butterworth D, et al. (1997) Carbohydrate and the cytokine response to 2.5 h of running. J App Physiol 82: 1662–1667.
    1. Pedersen BK, Hoffman-Goetz L (2000) Exercise and the immune system: regulation, integration, and adaptation. Physiol Rev 80: 1055–1081.
    1. Nemet D, Oh Y, Kim H-S, Hill M, Cooper DM (2002) Effect of intense exercise on inflammatory cytokines and growth mediators in adolescent boys. Pediatrics 110: 681–689.
    1. Tonoli C, Heyman E, Roelands B, Buyse L, Cheung SS, et al. (2012) Effects of Different Types of Acute and Chronic (Training) Exercise on Glycaemic Control in Type 1 Diabetes Mellitus: A Meta-Analysis. Sports Med 42: 1059–1080.
    1. Bracken R, West D, Stephens J, Kilduff L, Luzio S, et al. (2011) Impact of pre-exercise rapid-acting insulin reductions on ketogenesis following running in Type 1 diabetes. Diabet Med 28: 218–222.
    1. Diamond M, Simonson D, DeFronzo R (1989) Menstrual cyclicity has a profound effect on glucose homeostasis. Fertility and sterility 52: 204–208.
    1. ACSM (2010) Clinical Exercise Testing. In: Walter R, Gordon NF, Pescatello LS, ACSM's guidelines for exercise testing and prescription. 8th ed. Baltimore: American College of Sports Medicine.
    1. Dill D, Costill DL (1974) Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration. J App Physiol 37: 247–248.
    1. West DJ, Stephens JW, Bain SC, Kilduff LP, Luzio S, et al. (2011) A combined insulin reduction and carbohydrate feeding strategy 30 min before running best preserves blood glucose concentration after exercise through improved fuel oxidation in type 1 diabetes mellitus. J Sports Sci 29: 279–289.
    1. Hopkins W (2006) Estimating sample size for magnitude-based inferences. J Sport Sci 10: 63–70.
    1. Marliss EB, Vranic M (2002) Intense Exercise Has Unique Effects on Both Insulin Release and Its Roles in Glucoregulation Implications for Diabetes. Diabetes 51: 271–283.
    1. McGarry J (1996) Ellenberg and Rifkin's Diabetes Mellitus. In: Porte D, Sherwin RS, Baron A, JAMA: J Am Med Assoc. 5 ed. New York: McGraw-Hill. pp. 19–28.
    1. Balasse EO, Féry F (1989) Ketone body production and disposal: effects of fasting, diabetes, and exercise. Diabetes Metab Rev 5: 247–270.
    1. Kalra PR, Tigas S (2002) Regulation of lipolysis: natriuretic peptides and the development of cachexia. Int J Cardiol 85: 125–132.
    1. Fowler MJ (2008) Microvascular and macrovascular complications of diabetes. Clinical Diabetes 26: 77–82.
    1. Daneman D (2006) Type 1 diabetes. The Lancet 367: 847–858.
    1. Galassetti P, Iwanaga K, Pontello A, Zaldivar F, Flores R, et al. (2006) Effect of prior hyperglycemia on IL-6 responses to exercise in children with type 1 diabetes. Am J Physiol-Endocrinol Metab 290: E833–E839.
    1. Galassetti PR, Iwanaga K, Crisostomo M, Zaldivar FP, Larson J, et al. (2006) Inflammatory cytokine, growth factor and counterregulatory responses to exercise in children with type 1 diabetes and healthy controls. Pediatric Diabetes 7: 16–24.
    1. Rosa JS, Oliver SR, Flores RL, Ngo J, Milne GL, et al. (2011) Altered inflammatory, oxidative, and metabolic responses to exercise in pediatric obesity and type 1 diabetes. Pediatric Diabetes 12: 464–472.
    1. Rosa JS, Flores RL, Oliver SR, Pontello AM, Zaldivar FP, et al. (2010) Resting and exercise-induced IL-6 levels in children with Type 1 diabetes reflect hyperglycemic profiles during the previous 3 days. J App Physiol 108: 334–342.
    1. Jentjens R, Jeukendrup AE (2003) Determinants of post-exercise glycogen synthesis during short-term recovery. Sports Med 33: 117–144.
    1. Pedersen BK, Febbraio MA (2008) Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physioll Rev 88: 1379–1406.
    1. Viardot A, Grey ST, Mackay F, Chisholm D (2007) Potential antiinflammatory role of insulin via the preferential polarization of effector T cells toward a T helper 2 phenotype. Endocrinology 148: 346–353.
    1. Cryer PE (2008) The barrier of hypoglycemia in diabetes. Diabetes 57: 3169–3176.
    1. Brown RJ, Sinaii N, Rother KI (2008) Too Much Glucagon, Too Little Insulin Time course of pancreatic islet dysfunction in new-onset type 1 diabetes. Diabetes Care 31: 1403–1404.

Source: PubMed

3
Tilaa